Fact CheckerSign in

NCT07145749Active, not recruiting

Examining the Effects of Theory-based Education on Individuals' Sexual Behavior.

Investigation of the Effects of Transtheoretical Theory-based Education Given to Individuals Followed in Amatem on Their Sexual Risk Taking, AIDS Knowledge Levels and Protection Self-efficacy: a Randomized Controlled Trial.

Source: ClinicalTrials.gov · Last updated 28 Aug 2025

Brief summary (registry, in English)

The research was planned to examine the effect of the transtheoretic theory-based education given to individuals followed in AMATEM on their sexual risk-taking status, AIDS knowledge level and AIDS prevention self-efficacy. Research Hypotheses H0: Transtheoretical theory-based education given to individuals followed in AMATEM has no effect on their sexual risk taking, AIDS knowledge level and protection self-efficacy. H1-1: Transtheoretic theory-based education given to individuals followed in AMATEM has an effect on the level of sexual risk taking. H1-2: The transtheoretic theory-based education given to individuals followed in AMATEM is A

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
48 (actual)
First submitted
13 Aug 2024
Start date
7 Dec 2024
Primary completion date
Aug 2025
Lead sponsor
Saglik Bilimleri Universitesi
Diseases
HIV
NCT number
NCT07145749

What you commit to

  • Study type: Interventional
  • Participants enrolled: 48
  • From 7 Dec 2024 to the primary completion date, Aug 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Presence of visual, hearing, or communication disorders

Other

  • Refusing to participate voluntarily in the study

Who the study is looking for

  • Willing to participate voluntarily in the study
  • Age 18 years or older
  • Under probation and receiving treatment at AMATEM
  • Able to read and write (literate)

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Sakarya Sağlik Bilimleri Enstitüsü
Coordinator of this site? Confirm its status
SakaryaTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.